Ambroxol

Ambroxol was discovered to be safe and well tolerated throughout a phase 2 clinical investigation into treating Parkinson’s. A a cough suppressant, Ambroxol, thins and decongest mucus. Ambroxol boosts the levels of GCase, a protein that helps cells better eliminate waste proteins like alpha-synuclein, a biomarker for Parkinson’s disease, according to current studies. Ambroxol will […]